There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
Seeking Alpha on MSN1d
Novo Nordisk seeks to block compounded Victoza
Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of ...
Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver
The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...
FiercePharma1d
Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row
In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...
조선일보9d
FDA approves generic Victoza, expects improved supply of obesity drug Saxenda
It is expected that the FDA will soon approve this generic as an obesity treatment since the obesity drug Saxenda has the ...
ABC News12d
Patient Who Had No Luck With GLP-1 Drugs Found Success With Surgery
She went back to her doctor who put her on liraglutide (Saxenda), a different GLP-1 drug that she injected once a day, but it made her sick as well, although not as sick. Her doctor explained that ...
devdiscourse11d
Biocon and Zentiva Secure EU Approval for Diabetes and Weight Management Drug
Biocon Ltd, in collaboration with Zentiva, has obtained EU approval for the complex formulation Liraglutide, a generic ...
CNN12d
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
called Saxenda. “There are many people on this drug, and they will benefit by another generic version of it,” Dr. Harlan Krumholz, a cardiologist at Yale University and Yale New Haven Hospital ...